Johnson & Johnson (J&J) to Acquire Abbott Medical Optics
By Phartoonz
Updated
J&J Acquisition is to Strengthen Global Leadership in Eye Health Adding Cataract and Refractive Eye Surgery to Vision Care Portfolio. J&J will pay $4.325 billion in cash.
Abbott Medical Optics is a worldwide leader in ophthalmic surgery and is known for world-class intra-ocular lenses used in cataract surgery. The World Health Organization estimates that approximately 20 million people are blind from age-related cataracts and that there are at least 100 million eyes with compromised visual acuity caused by cataracts. These numbers are steadily rising due to population growth and increasing life expectancy.
Press release :
http://www.jnj.com/news/all/Johnson-Johnson-Announces-Agreement-to-Acquire-Abbott-Medical-Optics
Keep reading
TOP 10 Pharmaceutical companies 2018
Here is a list of the top 10 pharmaceutical companies 2018 Hoffmann-La Roche Ltd (Switzerland) Pfizer (U.S.) AbbVie (U.S.) Johnson & Johnson (U.S.) Sanofi (France) Merck & Co. (U.S.) Novartis (Switzerland) Gilead Sciences (U.S.) GlaxoSmithKline (U.K.) Amgen (U.S.)
Mar 11, 2018
Benznidazole first U.S. treatment for Chagas disease
Chagas disease Known as American trypanosomiasis, is a parasitic infection caused by Trypanosoma cruzi and can be transmitted through different routes, including contact with the feces of a certain insect, blood transfusions, or from a mother to her child during pregnancy. After years of infection, the disease can cause serious heart illness, and it also…
Aug 29, 2017
Radicava (edaravone) approved for ALS by FDA
What is Radicava? Do you remember the Ice Bucket Challenge, the challenge that carried out by most famous people and passed to others as an awareness campaign for amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease. Amyotrophic lateral sclerosis (ALS) ALS is a rare disease that attacks and kills the nerve cells…
May 5, 2017
Bavencio approved by FDA for metastatic Merkel cell carcinoma (MCC)
“While skin cancer is one of the most common cancers, patients with a rare form called Merkel cell cancer have not had an approved treatment option until now,” said Richard Pazdur, M.D., acting director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research and director of the…
Mar 23, 2017